Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19
D. Bohan, H. Van Ert, N. Ruggio, K. J. Rogers, M. Baddredine, J. A. A. Briseno, R. A. Rojas Chavez, B. Gao, T. Stokowy, E. Christakou, D. Micklem, G. Gausdal, H. Haim, J. Minna, J. B. Lorens, W. Maury
This study identifies PS receptors, including AXL, as facilitators of SARS-CoV-2 infection by enhancing virus entry into human lung cells, suggesting AXL as a therapeutic target for COVID-19.
bioRxiv · Jun 15, 2021Microbiology